Halozyme Therapeutics Inc (HALO) — Cash Flow-to-Debt Ratio
Halozyme Therapeutics Inc (HALO) has a Cash Flow-to-Debt Ratio of 0.10x as of September 2025, meaning its operating cash flow of $178.60 Million could theoretically repay 0% of its total liabilities ($1.72 Billion) in one year. Check Halozyme Therapeutics Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Halozyme Therapeutics Inc Cash Flow-to-Debt Ratio (2001–2024)
Historical debt coverage capacity for Halozyme Therapeutics Inc across 24 annual periods. Also explore how large is Halozyme Therapeutics Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Halozyme Therapeutics Inc (2001–2024)
Year-by-year debt coverage analysis for Halozyme Therapeutics Inc. For market capitalisation and broader financial context, see Halozyme Therapeutics Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.28x | $479.06 Million | $1.70 Billion | ▲ +19.6% |
| 2023 | 0.24x | $388.57 Million | $1.65 Billion | ▲ +64.0% |
| 2022 | 0.14x | $240.11 Million | $1.67 Billion | ▼ -56.5% |
| 2021 | 0.33x | $299.44 Million | $907.48 Million | ▲ +155.2% |
| 2020 | 0.13x | $55.45 Million | $428.88 Million | ▲ +171.8% |
| 2019 | -0.18x | $-85.42 Million | $474.11 Million | ▲ +30.3% |
| 2018 | -0.26x | $-49.50 Million | $191.36 Million | ▼ -160.1% |
| 2017 | 0.43x | $134.05 Million | $311.58 Million | ▲ +351.1% |
| 2016 | -0.17x | $-50.38 Million | $294.00 Million | ▲ +35.9% |
| 2015 | -0.27x | $-37.08 Million | $138.79 Million | ▲ +29.9% |
| 2014 | -0.38x | $-47.52 Million | $124.62 Million | ▲ +5.9% |
| 2013 | -0.41x | $-49.34 Million | $121.78 Million | ▲ +45.9% |
| 2012 | -0.75x | $-64.33 Million | $85.87 Million | ▼ -19.6% |
| 2011 | -0.63x | $-34.35 Million | $54.86 Million | ▲ +2.1% |
| 2010 | -0.64x | $-45.39 Million | $70.99 Million | ▼ -11.9% |
| 2009 | -0.57x | $-40.15 Million | $70.25 Million | ▲ +1.1% |
| 2008 | -0.58x | $-35.37 Million | $61.18 Million | ▼ -17791.0% |
| 2007 | 0.00x | $-147.66K | $45.69 Million | ▼ -101.1% |
| 2006 | 0.31x | $7.08 Million | $23.01 Million | ▲ +105.5% |
| 2005 | -5.64x | $-13.00 Million | $2.30 Million | ▼ -15.5% |
| 2004 | -4.89x | $-7.72 Million | $1.58 Million | ▼ -268.0% |
| 2003 | -1.33x | $-49.73K | $37.45K | ▲ +75.2% |
| 2002 | -5.35x | $-55.78K | $10.43K | ▲ +48.8% |
| 2001 | -10.45x | $-34.37K | $3.29K | — |